Grants and Contributions:
Title:
Support for Pharma SMEs in the Prairies
Agreement Number:
1020113
Agreement Value:
$67,380.00
Agreement Date:
Jul 1, 2024 - Jan 31, 2026
Description:
As a pilot project, the general objective of the proposed project is to identify and assist SME firms engaged in pharmaceutical development and manufacturing who will be undergoing a regulatory body (FDA, HC, EMA, etc) audit. Identification of firms, creation of awareness, and building of networks in quality assurance and regulatory compliance.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Organizations is to support Organizations in building and integrating the innovation capacity in Canada for the benefit of Firms in Canada, primarily SMEs and to support Organizations in providing innovation assistance services to SMEs in Canada.
Location:
Markham, Ontario, CA L3R 5B4
Reference Number:
172-2024-2025-Q2-1020113
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
124665852
Recipient Type:
Not-for-profit organization or charity
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 306 days. The total amended value is 12,599 dollars.
Amendment Date
Mar 14, 2025
Recipient's Legal Name:
National Pharmaceutical Sciences Group Inc.
Federal Riding Name:
Markham--Unionville
Federal Riding Number:
35056
Program:
Industrial Research Assistance Program – Contributions to Organizations
Program Purpose:
The purpose of IRAP Contributions to Organizations is to support Organizations in building and integrating the innovation capacity in Canada for the benefit of Firms in Canada, primarily SMEs and to support Organizations in providing innovation assistance services to SMEs in Canada.
Coverage:
IRAP Contributions to Organizations projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: